Cardinal Heart 2.0 is an International Space Station investigation using three-dimensional cardiac cultures derived from induced pluripotent stem cells to test whether clinically approved drugs reduce microgravity-induced changes in heart cell function.
Alerts are unavailable because this mission is no longer active.